Human Genome Sciences, Inc. (HGSI) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Human Genome Sciences, Inc. (HGSI)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
1127	105	0	HGSI

Emcee: Jeffrey Ogbar	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
252	Steven, The best will be that you again call HGSI and ask for clarification on	Miljenko Zuanic	-	2/23/1999
251	Miljenko, Thank you so much for posting a reply. It would be great for	Steven Rachbach	-	2/23/1999
250	Steven, Thanks for informative post. Still, there seams to be several confusi	Miljenko Zuanic	-	2/23/1999
249	I would like to clarify some of the confusing and misleading aspects of VEGF te	Steven Rachbach	-	2/22/1999
248	Human Genome Sciences Reports 1998 Financial Results ROCKVILLE, Md., Feb. 11	Steven Rachbach	-	2/11/1999
247	Human Genome Sciences Initiates Phase II Human ClinicalTrials Of KGF-2, a New	Steven Rachbach	-	2/10/1999
246	To all; Good news today :). But weak market response :( David	David Bogdanoff	-	1/27/1999
245	Promising results using VEGF in the treatment of coronary artery disease: Gene	Steven Rachbach	-	1/27/1999
244	The following should be accomplished by Humane Genome Science in 1999: -	Steven Rachbach	-	1/6/1999
243	David, New coronary blood vessels certainly aren't peripheral but I suppos	Steven Rachbach	-	12/29/1998
242	SR: << I am sure the generation of new blood vessels in the heart would	David Bogdanoff	-	12/29/1998
241	David, The typical causes of peripheral vascular disease are hypertension, hig	Steven Rachbach	-	12/28/1998
240	RMP; Thanks for article. Does anyone know typical causes of peripheral artery	David Bogdanoff	-	12/25/1998
239	Here's another article which should provide some positive spin for HGSI: b	RMP	-	12/23/1998
238	Today the NY Times came out with a report of stem cells and cell signaling. GER	Henry Niman	-	12/8/1998
237	Has anyone noticed how difficult it is to trade this stock now. It is often on	guido leone	-	11/15/1998
236	Third Q. earnings Report.... Human Genome Sciences Reports Third Quarter Finan	Steven Rachbach	-	10/29/1998
235	Thanks for your response and I agree entirely with you. One never knows what	Steven Rachbach	-	10/12/1998
234	S; Thank you for sharing your information with us. Althought your friend'	David Bogdanoff	-	10/12/1998
233	I asked an Oncologist acquaintance of mine to review the literature on MPIF an	Steven Rachbach	-	10/11/1998
232	<b>I believe that the first successful Phase II trial for one of its drug	Larry Dreher	-	10/6/1998
231	Testing is proceeding at HGSI. Phase 1 testing is in the analysis stage for K	Steven Rachbach	-	10/6/1998
230	(NewsTraders) -- A group including members of the influential Texas-based Bass	NewsTrader	-	9/14/1998
229	Everything bio tech is down big. A month ago i had VICAL at 17. Now its 8. Pr	AmericanDane	-	9/4/1998
228	The recent decline in price makes you wonder if the Bass boys had some margin c	Elmer	-	9/3/1998

Go to reply# or date (mm/dd/yy):